Literature DB >> 6974052

Immunosuppression by 2' deoxycoformycin: studies on the mode of administration.

E M Sordillo, S Ikehara, R A Good, P P Trotta.   

Abstract

Mesh：

Substances：

Year:  1981        PMID： 6974052     DOI： 10.1016/0008-8749(81)90005-8

Source DB:  PubMed          Journal:  Cell Immunol        ISSN： 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  3 in total

1.  Pathologic findings in adenosine deaminase-deficient severe combined immunodeficiency. I. Kidney, adrenal, and chondro-osseous tissue alterations.

Authors:  H Ratech; M A Greco; G Gallo; D L Rimoin; H Kamino; R Hirschhorn
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

Review 2.  Pentostatin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in lymphoproliferative disorders.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

3.  Effects of deoxycoformycin in mice. III. A murine model reproducing multi-system pathology of human adenosine deaminase deficiency.

Authors:  H Ratech; R Hirschhorn; G J Thorbecke
Journal:  Am J Pathol       Date:  1985-04       Impact factor: 4.307
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.